Company intelligence / Profile preview

Bendit Technologies

Petah Tikva, Israel

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Bendit Technologies has received FDA 510(k) clearance and CE Mark for its steerable microcatheters, initially for peripheral use, and has reported positive outcomes in exploratory multicenter human trials and retrospective neuro-interventional series using its Bendit 21 and related catheters for complex neurovascular and peripheral procedures, with device-related safety and successful navigation/treatment as primary endpoints.[3][4]

Therapeutic areas: OncologyCardiovascularNeurology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Varian Medical Systems (strategic equity investment, board representation, and collaboration on interventional oncology and embolic therapies)[1][3]

Beyond the preview

Go deeper on Bendit Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bendit Technologies.

Explore the full profile